KromaTid Inks European Distribution Deal with Tebu-bio | GenomeWeb

NEW YORK (GenomeWeb) – KromaTid today announced it has selected Tebu-bio as its European distribution partner. 

Tebu-bio will distribute Fort Collins, Colo.-based KromaTid's genome imaging assays, which can determine DNA sequence, location, and orientation in a single test. KromaTiD's assays can detect genetic rearrangements, such as chromosomal inversions and translocations, that are missed by other diagnostic tools, the firm said in a statement. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.